In addition, our recent studies suggest that Grb2 (manuscript submitted) and c-Src [19], both of which showed in vitro and in vivo binding with AQP5, could be some of the candidate adaptor molecules which interact with AQP5 in CML cells. This evidence concerns the gene AQP5 and chronic myelogenous leukemia, BCR-ABL1 positive.